{"id":9810,"date":"2020-10-02T13:15:17","date_gmt":"2020-10-02T13:15:17","guid":{"rendered":"https:\/\/www.incirliseviye.com\/?p=9810"},"modified":"2020-10-02T13:15:17","modified_gmt":"2020-10-02T13:15:17","slug":"how-big-pharmas-industrial-waste-is-fueling-the-rise-in-superbugs-worldwide","status":"publish","type":"post","link":"https:\/\/onhee.com\/?p=9810","title":{"rendered":"How Big Pharma\u2019s Industrial Waste Is Fueling the Rise in Superbugs Worldwide"},"content":{"rendered":"
\n

Pharmaceutical companies are fuelling the rise of superbugs by manufacturing drugs in factories that leak industrial waste, says a new report\u00a0which calls on them to radically improve their supply chains.<\/p>\n

Factories in China and India \u2013 where the majority of the world\u2019s antibiotics are produced \u2013 are releasing untreated waste fluid containing active ingredients into surrounding areas, highlights the report by a coalition of environmental and public health organisations.<\/p>\n

Ingredients used in antibiotics get into the local soil and water systems, leading to bacteria in the environment becoming resistant to the drugs. They are able to exchange genetic material with other nearby germs, spreading antibiotic resistance around the world, the report claims.<\/p>\n

Ahead of a United Nations summit on antimicrobial resistance in New York next week, the report \u2013 by\u00a0the European Public Health Alliance (EPHA) and pressure group Changing Markets \u2013 calls on major drug companies to tackle the pollution which is one of its root causes.<\/p>\n

They\u00a0say the industry\u00a0is ignoring the pollution in its supply chain while it drives the proliferation of drug resistant bacteria \u2013 a phenomenon which kills an estimated 25,000 people across Europe and globally poses \u201cas big a threat as terrorism,\u201d according to NHS England\u2019s Chief Medical Officer Dame Sally Davies.<\/p>\n

If no action is taken antimicrobial resistance (AMR) will kill 10 million people worldwide every year \u2013 more than cancer \u2013 according to an independent review into AMR last year led by economist Professor Jim O\u2019Neill.<\/p>\n

Changing Markets compiled previous detailed reports and conducted its own on-the-ground research looking at a range of Chinese and Indian drug manufacturing plants making products for some of the world\u2019s biggest pharmaceutical companies. One of the world\u2019s biggest antibiotic production plants, in Inner Mongolia, was found in 2014 to be \u201cpumping tonnes of toxic and antibiotic-rich effluent waste into the fields and waterways surrounding the factory,\u201d according to Chinese state television.<\/p>\n

In India, where much of the raw material produced by Chinese factories is turned into finished drugs, various studies have found \u201chigh levels of hazardous waste\u201d and \u201clarge volumes of effluent waste\u201d being dumped into the environment. About a quarter of UK medicines are made in India.<\/p>\n

The factory pollution mixes with waste from farms and sewage plants, providing an ideal breeding ground for the drug-resistant bacteria. Once established in the environment, the germs can spread around the world through air and water, and by travellers visiting countries where the bacteria are prevalent.<\/p>\n

A drug-resistant bacteria first found in India in 2014 has since been found in more than 70 countries around the world, the report highlights.<\/p>\n

Most major drug companies display a \u201cshocking lack of concern\u201d about pollution in their supply chains, Changing Markets\u00a0claims. It is calling for companies that fail to demand environmentally sound manufacturing and waste treatment techniques from their suppliers to be blacklisted.<\/p>\n

Large purchasers of medicines, including health services, hospitals and pharmacies should push for cleaner production processes, it adds.<\/p>\n

Natasha Hurley, a spokeswoman for Changing Markets, said: \u201cBig Pharma\u2019s role in fuelling drug resistance is all too often overlooked when policies to curb the spread of AMR are being discussed.<\/p>\n

\u201cOur research has shown that the industry is failing to take the necessary action to address the threat of a looming environmental and public health crisis in which it is playing a key part.\u201d<\/p>\n

\n
\n

SCROLL TO CONTINUE WITH CONTENT<\/p>\n<\/p><\/div>\n<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div>\n

Modern medical systems rely on antibiotics to prevent people becoming ill with bacterial infections.<\/p>\n

The drugs also prevent infection during surgery and treatments like chemotherapy, which can wipe out the body\u2019s immune system.<\/p>\n

As the bugs become resistant to the drugs used to treat them, experts fear more people will die of infections \u2013 and common medical procedures will become high risk.<\/p>\n

Next week global leaders will meet for a United Nations conference in New York to discuss the growing problem of AMR.<\/p>\n

Resistance is fuelled by the overuse of antibiotics in farming as well as in human medicine, a topic the Bureau of Investigative Journalism has been researching for more than six months.<\/p>\n

Earlier this year, the Bureau analysed figures released by the Veterinary Medicines Directorate, which regulates what drugs vets prescribe for use in British farming and agriculture, and revealed a significant increase in sales of some critically important antibiotics.<\/p>\n

A \u201ccritically important\u201d antibiotic is one which is either the sole treatment option or one of few alternatives for a serious infectious disease in humans.<\/p>\n

They also treat diseases humans can catch from non-human sources such as animals, water, food or the environment, including some drug-resistant diseases.<\/p>\n

The rise in sales of critically important antibiotics is happening despite the fact it is now known that resistant forms of certain food poisoning illnesses, including campylobacter, and some variations of the superbug MRSA, are directly linked to antibiotic use on farms.<\/p>\n

In April, the Bureau revealed growing levels of resistance among campylobacter bacteria, which is commonly found in supermarket chickens. The bug infects up to 300,000 people in the UK each year, hospitalising about 1,000 and killing about 100.<\/p>\n

Previously unpublished data collated by Public Health England showed almost one in two of all human campylobacter cases tested in England was resistant to the antibiotic ciprofloxacin.<\/p>\n

Ciprofloxacin is one of several drugs doctors can turn to when victims of food poisoning develop complications, and is also used to treat other conditions such as urinary tract infections.<\/p>\n

Responding the EPHA and Changing Markets\u2019 report, Emma Rose from the campaign group the Alliance to Save our Antibiotics said: \u201cToday\u2019s briefing casts light on how big polluting factories are fueling the emergence of drug resistant bacteria.<\/p>\n

\u201cWith prescribers of both human and veterinary medicine increasingly urged to take action on antibiotics, the pharmaceutical industry must now play its part in tackling this crisis.\u201d<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\u00a9 2016 Bureau of Investigative Journalism<\/p><\/div>\n<\/div>\n<\/div>\n<\/div>\n

Click Here: cd universidad catolica<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Pharmaceutical companies are fuelling the rise of superbugs by manufacturing drugs in factories that leak industrial waste, says a new report\u00a0which calls on them to radically improve their supply chains. Factories in China and India \u2013 where the majority of the world\u2019s antibiotics are produced \u2013 are releasing untreated waste fluid containing active ingredients into … <\/p>\n

Read more “How Big Pharma\u2019s Industrial Waste Is Fueling the Rise in Superbugs Worldwide”<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-9810","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/onhee.com\/index.php?rest_route=\/wp\/v2\/posts\/9810","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/onhee.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/onhee.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/onhee.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/onhee.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=9810"}],"version-history":[{"count":0,"href":"https:\/\/onhee.com\/index.php?rest_route=\/wp\/v2\/posts\/9810\/revisions"}],"wp:attachment":[{"href":"https:\/\/onhee.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=9810"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/onhee.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=9810"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/onhee.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=9810"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}